Loading insider details...
Beta
Latest Form 4 (Feb 9, 2024): Tax Withholding of 49,198 CMPX shares, $71.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 9, 2024 | Compass Therapeutics, Inc. (CMPX) | Tax Withholding | 49,198 | $71.3K |
| Jan 10, 2024 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 1,753,125 | $3.38M |
| Nov 21, 2023 | Compass Therapeutics, Inc. (CMPX) | Tax Withholding | 64,415 | $96.6K |
| Feb 9, 2023 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 400,000 | n/a |
| Jan 23, 2023 | Ayala Pharmaceuticals, Inc. (ADXS) | Grant/Award | 1,639 | n/a |
| Nov 25, 2022 | Compass Therapeutics, Inc. (CMPX) | Sale | 14,929 | $62.6K |
| Nov 22, 2022 | Compass Therapeutics, Inc. (CMPX) | Sale | 6,226 | $27.4K |
| Feb 19, 2022 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 500,000 | n/a |
| Nov 19, 2021 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 600,000 | n/a |
| Mar 1, 2021 | Compass Therapeutics, Inc. (CMPX) | Grant/Award | 400,000 | n/a |